Natus welcomes Optima Medical to the Natus family of solutions
The shareholders of Optima Medical Limited have sold the company to Natus Medical Incorporated.
Optima Medical is one of the UK and Ireland’s leading supplier of neurodiagnostic equipment and accessories (EEG, Sleep, EMG, IOM). Since it was founded in 1999, Optima has installed thousands of systems in hospitals throughout the UK and Ireland. The company has built its reputation through supplying high-performance equipment combined with technical and clinical expertise. Its team consists of highly experienced engineers, product experts and clinical specialists trained and qualified to support customers throughout the life of their equipment.
Natus delivers solutions to screen, diagnose and treat disorders affecting the brain, neural pathways and eight sensory nervous systems, its aim being to advance the standard of care and improve patient outcomes and quality of life. Natus offers hardware, advanced software and algorithms, and consumables that provide stimulus, acquire and monitor physiological signals, and capture the body’s response. With sales in over 100 countries, Natus is a global leader in neurodiagnostics.
With a long-standing history as a trusted distribution partner of Natus Medical, the acquisition of Optima signifies a significant step forward, elevating their already successful partnership to a new phase. Together, they are able to enhance their shared goal of providing industry leading products and exceptional customer support, bringing it closer to their customers within the British Isles.
Oaklins S&W, based in the UK, acted as lead advisor to the shareholders of Optima.
Talk to the deal team
Related deals
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Learn moreMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Learn moreQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Learn more